BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 21763961)

  • 21. Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience.
    Hurst FP; Jindal RM; Graham LJ; Falta EM; Elster EA; Stackhouse GB; Agodoa LY; Lentine KL; Salifu MO; Abbott KC
    Transplantation; 2010 Oct; 90(8):898-904. PubMed ID: 21248500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of renal cell cancer.
    Dayal HH; Wilkinson GS
    Semin Urol; 1989 Aug; 7(3):139-43. PubMed ID: 2690257
    [No Abstract]   [Full Text] [Related]  

  • 23. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: "Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the women's health initiative (United States)".
    Sharifi N; Farrar WL
    Am J Epidemiol; 2008 Apr; 167(8):1016; author reply 1016. PubMed ID: 18344511
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is there a link between the occurrence of Kidney cancer and hypertension in Tunisian population?].
    Ferchichi I; Kourda N; Derouiche A; Baltagi S; Chebil M; Benammar-Elgaaied A
    Tunis Med; 2012 May; 90(5):397-400. PubMed ID: 22585648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal cell carcinoma and end stage renal disease.
    Farivar-Mohseni H; Perlmutter AE; Wilson S; Shingleton WB; Bigler SA; Fowler JE
    J Urol; 2006 Jun; 175(6):2018-20; discussion 2021. PubMed ID: 16697788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Exogenous risk factors for parenchymal carcinoma of the kidney].
    D'Amico A; Piacentini I; Righetti R; Curti P; Ficarra V
    Arch Ital Urol Androl; 2001 Mar; 73(1):49-55. PubMed ID: 11505815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity and risk of renal cell cancer.
    Chow WH; McLaughlin JK; Mandel JS; Wacholder S; Niwa S; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):17-21. PubMed ID: 8770461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: The epidemiology of renal cell carcinoma.
    Parker AS
    J Urol; 2007 May; 177(5):1953; author reply 1953-4. PubMed ID: 17437854
    [No Abstract]   [Full Text] [Related]  

  • 30. Polymorphisms of DNA repair genes are associated with renal cell carcinoma.
    Hirata H; Hinoda Y; Matsuyama H; Tanaka Y; Okayama N; Suehiro Y; Zhao H; Urakami S; Kawamoto K; Kawakami T; Igawa M; Naito K; Dahiya R
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1058-62. PubMed ID: 16510122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity, interrelated mechanisms, and exposures and kidney cancer.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):270-9. PubMed ID: 11769879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of bilateral renal cell cancer.
    Wiklund F; Tretli S; Choueiri TK; Signoretti S; Fall K; Adami HO
    J Clin Oncol; 2009 Aug; 27(23):3737-41. PubMed ID: 19597028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiologic aspects of renal cell carcinoma.
    McLaughlin JK; Lipworth L; Tarone RE
    Semin Oncol; 2006 Oct; 33(5):527-33. PubMed ID: 17045081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of renal cell carcinoma.
    Lindblad P
    Scand J Surg; 2004; 93(2):88-96. PubMed ID: 15285559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
    Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology and risk factors of kidney cancer.
    Janout V; Janoutová G
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2004 Jul; 148(1):95-101. PubMed ID: 15523556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Active and passive smoking and risk of renal cell carcinoma in Canada.
    Hu J; Ugnat AM;
    Eur J Cancer; 2005 Mar; 41(5):770-8. PubMed ID: 15763654
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity, cholesterol, and clear-cell renal cell carcinoma (RCC).
    Drabkin HA; Gemmill RM
    Adv Cancer Res; 2010; 107():39-56. PubMed ID: 20399960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study.
    Lindblad P; Wolk A; Bergström R; Persson I; Adami HO
    Cancer Epidemiol Biomarkers Prev; 1994 Dec; 3(8):631-9. PubMed ID: 7881335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human renal-cell carcinoma--epidemiological and mechanistic aspects.
    Mellemgaard A
    IARC Sci Publ; 1999; (147):69-80. PubMed ID: 10457911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.